These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9778542)

  • 1. Use of spectral turbulence analysis for the identification of patients at high risk for ventricular fibrillation and sudden death in patients with hypertrophic cardiomyopathy.
    Englund A; Hnatkova K; Kulakowski P; Elliot PM; Malik M; McKenna WJ
    Cardiology; 1998 Oct; 90(2):79-82. PubMed ID: 9778542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wavelet decomposition analysis of the signal averaged electrocardiogram used for risk stratification of patients with hypertrophic cardiomyopathy.
    Englund A; Hnatkova K; Kulakowski P; Elliot PM; McKenna WJ; Malik M
    Eur Heart J; 1998 Sep; 19(9):1383-90. PubMed ID: 9792265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Gimeno JR; Tomé-Esteban M; Lofiego C; Hurtado J; Pantazis A; Mist B; Lambiase P; McKenna WJ; Elliott PM
    Eur Heart J; 2009 Nov; 30(21):2599-605. PubMed ID: 19689975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectral turbulence and late potentials in the signal-averaged electrocardiograms of patients with monomorphic ventricular tachycardia versus resuscitated ventricular fibrillation.
    Gottfridsson C; Sandstedt B; Karlsson T; Edvardsson N
    Scand Cardiovasc J; 2000 Jun; 34(3):261-71. PubMed ID: 10935772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QRS Fragmentation and QTc Duration Relate to Malignant Ventricular Tachyarrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy.
    Debonnaire P; Katsanos S; Joyce E; VAN DEN Brink OV; Atsma DE; Schalij MJ; Bax JJ; Delgado V; Marsan NA
    J Cardiovasc Electrophysiol; 2015 May; 26(5):547-55. PubMed ID: 25648421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of time and frequency domain, and spectral temporal mapping analysis of the signal-averaged electrocardiogram in identification of patients with hypertrophic cardiomyopathy at increased risk of sudden death.
    Kulakowski P; Counihan PJ; Camm AJ; McKenna WJ
    Eur Heart J; 1993 Jul; 14(7):941-50. PubMed ID: 8375420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive prognostic significance of ejection fraction for ESC risk model in hypertrophic cardiomyopathy patients.
    Hen Y; Iguchi N; Kanisawa M; Takada K; Machida H; Takara A; Teraoka K; Takamisawa I; Takayama M; Yoshikawa T
    Heart Vessels; 2020 Mar; 35(3):391-398. PubMed ID: 31482217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience.
    Weinstock J; Bader YH; Maron MS; Rowin EJ; Link MS
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular fibrillation in hypertrophic cardiomyopathy is associated with increased fractionation of paced right ventricular electrograms.
    Saumarez RC; Camm AJ; Panagos A; Gill JS; Stewart JT; de Belder MA; Simpson IA; McKenna WJ
    Circulation; 1992 Aug; 86(2):467-74. PubMed ID: 1638716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients.
    Alsheikh-Ali AA; Link MS; Semsarian C; Shen WK; Estes NA; Maron MS; Haas TS; Formisano F; Boriani G; Spirito P; Maron BJ
    Heart Rhythm; 2013 Feb; 10(2):214-8. PubMed ID: 23041573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy.
    Wang W; Lian Z; Rowin EJ; Maron BJ; Maron MS; Link MS
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28314849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular tachyarrhythmia associated with hypertrophic cardiomyopathy: incidence, prognosis, and relation to type of hypertrophy.
    Furushima H; Chinushi M; Iijima K; Sanada A; Izumi D; Hosaka Y; Aizawa Y
    J Cardiovasc Electrophysiol; 2010 Sep; 21(9):991-9. PubMed ID: 20487113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular fibrillation induced by transesophageal atrial pacing in hypertrophic cardiomyopathy.
    Favale S; Di Biase M; Rizzo U; Minafra F; Rizzon P
    Eur Heart J; 1987 Aug; 8(8):912-6. PubMed ID: 3665949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sudden death and ventricular fibrillation of possible ischemic origin in a boy with hypertrophic myocardiopathy].
    Gutiérrez Díez A; Tamariz-Martel Moreno A; Baño Rodrigo A; Serrano González A
    Rev Esp Cardiol; 2000 Feb; 53(2):290-3. PubMed ID: 10734761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sudden death in hypertrophic obstructive and non-obstructive cardiomyopathy: can it be prevented?].
    Grobéty M; Schlaepfer J; Kappenberger L; Fromer M
    Schweiz Med Wochenschr; 1997 Apr; 127(15):623-30. PubMed ID: 9198888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
    Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
    N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sudden death in noncoronary heart disease is associated with delayed paced ventricular activation.
    Saumarez RC; Chojnowska L; Derksen R; Pytkowski M; Sterlinski M; Huang CL; Sadoul N; Hauer RN; Ruzyłło W; Grace AA
    Circulation; 2003 May; 107(20):2595-600. PubMed ID: 12743006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aborted sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Casey SA; Almquist AK
    J Cardiovasc Electrophysiol; 1999 Feb; 10(2):263. PubMed ID: 10090231
    [No Abstract]   [Full Text] [Related]  

  • 19. Ventricular fibrillation in MYH7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy.
    Christiaans I; Lekanne dit Deprez RH; van Langen IM; Wilde AA
    Heart Rhythm; 2009 Sep; 6(9):1366-9. PubMed ID: 19539541
    [No Abstract]   [Full Text] [Related]  

  • 20. Eligibility for the Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Hypertrophic Cardiomyopathy.
    Francia P; Adduci C; Palano F; Semprini L; Serdoz A; Montesanti D; Santini D; Musumeci B; Salvati A; Volpe M; Autore C
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):893-899. PubMed ID: 25996259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.